Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07738068) titled 'Progesterone Luteal Support in Unexplained Infertility Management' on July 22.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).

Primary Sponsor: Simone Broer

Condition: Infertility Female Infertility Subfertility Infertility Primary Infertility Secondary Subfertility, Female

Intervention: Drug: Utrogestan(R) 200 mg Soft Capsule

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: August 1, 2026

Target Sample Size: 640

To know more, visit ...